Kisqali Femara Co-Pack
Kisqali With an AI and Kisqali Femara Co-Pack Approved for Early High-Risk Breast Cancer
The FDA has approved Kisqali with an aromatase inhibitor for the adjuvant treatment of adults with HR-positive, ...
SEPTEMBER 17, 2024
FDA Approves Kisqali Femara Co-Pack
The co-pack is the first, and only currently available, combination pack with two prescription products for ...
MAY 10, 2017
Load more